Our Long Road to War With Iran
US Officials Warn That Iran Is Opening Up a New Front in the...
What Can We Do About Islam in America?
More Questions Have Surfaced About Eric Swalwell's Eligibility to Run for California Gover...
All It Took for Democrats to Cave on DHS Funding Was Four Terrorist...
Fox News Just Found More Medicare Fraud in California
The New York City Council Is About to Make Things Even More Expensive...
Woman Launches GoFundMe to Help Her DoorDash Driver Finally Retire
Gavin Newsom's Early Release Law Just Set Criminal With 300-Year Sentence Free
Secretary Hegseth Provided an Update on Operation Epic Fury. Here's What He Said.
Here's More Proof Mamdani's Wife Has an Antisemitism Problem
Is Buzzfeed About to Go Bust?
They’re Losing. And They Know It.
Even Obama's Former DHS Secretary Is Calling On Democrats to Fund DHS
California Scrambles to Bolster Drone Defenses After FBI Warns Iran May Target West...
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos